Johnson & Johnson sued Samsung Bioepis for allegedly breaching a contract agreement over its launch of a biosimilar to ...

Johnson & Johnson filed a lawsuit against Samsung Bioepis for allegedly breaching their agreement over the launch of ...

Samsung Bioepis has allegedly sub-licensed its Stelara biosimilar rights to a health conglomerate, breaching a previous ...

Three ustekinumab biosimilars enter the US market, expanding access to more affordable options referencing Stelara ...

Here's a look at how weekly regional gas prices changed in Central Atlantic region last week compared with the week prior.

On this week’s episode of “The Daily Show,” Jon Stewart accidentally sliced his hand open while smashing a coffee mug on his ...

Canada's Marketing Hall of Legends, one of Canada's most respected and renowned industry awards, is proud to announce this ...

Washington's push to swiftly end the conflict in Ukraine has sparked speculation that Western brands may want to return to ...

Last year marked an all-time record of 18 Food and Drug Administration (FDA) biosimilar approvals, bringing the total number ...

AAM said the law sets up a process under which a drug would have price controls applied before a generic or biosimilar even ...